We are a diagnostics company with the mission to make the detection, the diagnosis, and the treatment and monitoring of an individual’s health easier and faster. We were founded on innovative research and technology development and have been in business since 1993. We have been publicly traded on NASDAQ (symbol: NGEN) since 1998. During 2007, we significantly restructured our operations. In the fourth quarter of 2007, we decided to close one of our three product lines, the micro array platform, and focus on products and technologies we acquired in the past four years. Although the micro array platform was technologically a success, the market for highly complex molecular testing remains small and we can no longer support this product line as we wait for the market to grow.
Company profile
Ticker
NGEN
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Nanogen Inc
SEC CIK
Corporate docs
IRS number
330489621
Latest filings (excl ownership)
REVOKED
Registration or securities revoked
7 May 14
8-K
Departure of Directors or Certain Officers
14 Aug 09
8-K
Nanogen Completes Asset Sale
9 Jul 09
8-K
Nanogen Enters Asset Purchase Agreement with Elitech
15 May 09
8-K
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
30 Mar 09
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
27 Mar 09
NT 10-K
Notice of late annual filing
27 Mar 09
25-NSE
Exchange delisting
26 Mar 09
8-K
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
13 Mar 09
8-K
Nanogen Reports 2008 Preliminary Unaudited
6 Mar 09
Latest ownership filings
No filings